Pharmacological ascorbate (intravenous vitamin C) has been used as a complementary medication by health care professionals. Initial work by Linus Pauling, Ph.D., suggested the drug has efficacy against cancer. Professor Pauling's work utilized intravenous ascorbate, and the University of Iowa has continued this work, investigating pharmacological ascorbate through rigorous clinical trials as well as investigating the mechanisms behind why it may work. Cancer Cell published initial work done by University of Iowa's ascorbate team. Kellie Bodeker, a current Ph.D. student, serves as the regulatory manager for these trials, including protocol/study design, data capture, and regulatory liaison for our investigator-held investigational new drug.